The independent website for Australian pharmacists

Medicines

Obesity drug market tipped to slow

11/03/2010 | Poor efficacy and negative side effects will have a detrimental effect on the sale and development of obesity drugs, according to a forecast by Datamonitor.


Erbitux pushing for another PBS listing

11/03/2010 | Erbitux (cetuximab) is being considered for PBS listing by the Pharmaceutical Benefits Advisory Committee this week for the treatment of metastatic bowel cancer.


OTC industry stands behind NSAIDs

10/03/2010 | Non-steroidal anti-inflammatory drugs (NSAIDs) played an important role in short term pain relief for the majority of consumers, the group representing the over-the-counter medicine sector has declared.


Patients unaware of NSAID effects

10/03/2010 | More than 70 per cent of consumers who took over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) were not aware the drugs' long term-effects, according to a new survey carried out on behalf of the Gut Foundation. 1 comment


Nebilet effectiveness against heart failure questioned

10/03/2010 | A new selective beta blocker used in treating chronic heart failure has "less robust evidence" of a benefit to survival, according to the National Prescribing Service.


New approach needed for kids' chronic pain

09/03/2010 | Treatment of chronic pain in children must involve psychological and environmental considerations and steer clear of opioids, a prominent pain expert has cautioned.


Galvus wins TGA approval

09/03/2010 | A new treatment for type 2 diabetes has been approved by the Therapeutic Goods Administration.


Roche drops new RA drug

09/03/2010 | A late-stage trial for a new rheumatoid arthritis and lupus drug was suspended by drug maker Roche this week after several patients died from infections.


New option for cardio protection

08/03/2010 | Antihypertensive agent Micardis (telmisartan) 80mg has been approved for the prevention of cardiovascular morbidity and mortality in patients with vascular disease or high-risk diabetes.


Pradaxa set for PBS listing

08/03/2010 | Australia's first oral direct thrombin inhibitor is set to be listed on the PBS for the prevention of venous thromboembolism in patients undergoing total hip or knee replacement. 1 comment


Recent newsletters

Newsletter archive

Recent comments

Most viewed articles this week

Related sites